NIH-funded research R01 grant

Using engineered materials to help heal lymphatic systems in lymphedema patients

Official title: Engineered biomaterials for promoting lymphatic regeneration in lymphedema

Funded at Georgia Institute of Technology · NIH-11106116 · Data updated 2026-11-12

This study is looking to make lymphedema treatments better by using new materials and methods to help your body grow healthy lymphatic vessels after surgery, so you can feel better and have improved results.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJune 3, 2025
Project endApril 30, 2029
Funding year2025
Award (this year)$502,294
NIH project number1R01HL179060-01
Project IDNIH-11106116 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from lymphedema, particularly those who have undergone lymph node dissection or irradiation.

Less likely to help

Patients with lymphedema not caused by lymph node issues or those who have other unrelated medical conditions may not benefit from this research.

What this research studies

This research focuses on improving treatments for lymphedema, a condition where fluid accumulates in limbs due to lymphatic system issues. The team aims to enhance current surgical methods by integrating advanced biomaterials and targeted delivery systems to promote lymphatic regeneration. They will test various formulations of hydrogels and lipid nanoparticles that deliver growth factors to stimulate the growth of lymphatic vessels. This approach seeks to improve patient outcomes after surgeries like vascularized lymph node transfer.

Why it matters

Potential benefit: If successful, this research could significantly improve the effectiveness of lymphedema treatments, leading to better quality of life for patients.

How similar studies have gone: Previous research has shown promise in using biomaterials for lymphatic regeneration, indicating potential for success in this novel approach.

Where this research is happening

  • Georgia Institute of Technology
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Dixon, James Brandon — Georgia Institute of Technology
  • Study coordinator: Dixon, James Brandon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.